Alector, Inc. Earnings Per Share, Basic and Diluted
Alector, Inc. (ALEC) reported Earnings Per Share, Basic and Diluted of -$0.54 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-05
- Alector, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.54.
- Alector, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.69.
- Alector, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.66.
- Alector, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.66.
- Alector, Inc. earnings per share, basic and diluted for fiscal 2021 was -$0.45.
- Alector, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.45.
- Alector, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.71.
- Alector, Inc. earnings per share, basic and diluted for fiscal 2018 was -$4.62.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.54 10-Q · filed 2022-05-05 | |||
| 2021-12-31 | -$0.45 10-K · filed 2022-02-24 | |||
| 2021-06-30 | -$0.69 10-Q · filed 2021-08-03 | -$1.35 10-Q · filed 2021-08-03 | ||
| 2021-03-31 | -$0.66 10-Q · filed 2022-05-05 | -$1.32 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.99 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.57 derived: net income ÷ weighted average shares · filed 2023-02-28 |
| 2020-12-31 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.33 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$1.91 derived: net income ÷ weighted average shares · filed 2023-02-28 | -$2.45 10-K · filed 2022-02-24 |
| 2020-09-30 | -$0.67 10-Q · filed 2020-11-10 | -$1.25 derived: net income ÷ weighted average shares · filed 2021-11-04 | -$1.78 10-Q · filed 2020-11-10 | -$2.25 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-06-30 | -$0.58 10-Q · filed 2021-08-03 | -$1.11 10-Q · filed 2021-08-03 | -$1.57 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$2.04 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2020-03-31 | -$0.53 10-Q · filed 2021-05-05 | -$0.99 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.46 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.83 derived: net income ÷ weighted average shares · filed 2022-02-24 |
| 2019-12-31 | -$0.45 10-K · filed 2020-03-24 | -$0.92 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.28 derived: net income ÷ weighted average shares · filed 2022-02-24 | -$1.71 10-K · filed 2022-02-24 |
| 2019-09-30 | -$0.47 10-Q · filed 2020-11-10 | -$0.83 derived: net income ÷ weighted average shares · filed 2020-11-10 | -$1.25 10-Q · filed 2020-11-10 | -$1.94 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-06-30 | -$0.36 10-Q · filed 2020-08-11 | -$0.77 10-Q · filed 2020-08-11 | -$1.48 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.26 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2019-03-31 | -$0.42 10-Q · filed 2020-05-13 | -$1.29 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$2.29 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.19 derived: net income ÷ weighted average shares · filed 2021-02-25 |
| 2018-12-31 | -$1.48 10-K · filed 2020-03-24 | -$2.82 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$3.83 derived: net income ÷ weighted average shares · filed 2021-02-25 | -$4.62 10-K · filed 2021-02-25 |
| 2018-09-30 | -$1.34 10-K · filed 2020-03-24 | -$2.34 derived: net income ÷ weighted average shares · filed 2020-03-24 | -$3.13 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$1.00 10-K · filed 2020-03-24 | -$1.78 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | -$0.78 10-K · filed 2020-03-24 | |||
| 2017-12-31 | -$3.55 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |